An Evaluation of Neuronal PARP‐1 and Caspase‐3 Levels in the Brain Tissue of Female Rats Exposed to Electromagnetic Fields at Different Gestational Stages
International Journal of Developmental Neuroscience · 2025-02 · 85 (1)
DOI: 10.1002/jdn.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, online erschienen am 18.02.2025. Verfasst von Kıymet Kübra Tüfekci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Faculty of Medicine, Kastamonu University, Kastamonu, Turkey. Hauptthemen laut MEDLINE: Electromagnetic Fields, Caspase 3, Prenatal Exposure Delayed Effects, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Foetal exposure to electromagnetic fields (EMFs) may cause marked neurocognitive impairment, although the mechanisms involved are still unclear. EMF induces region‐specific neuronal and astroglial death in the rat hippocampus. Poly (ADP‐ribose) polymerase‐1 (PARP‐1) regulates necrosis, apoptosis and other cellular processes occurring following injury. This study, therefore, investigated whether PARP‐1 also regulates neuronal responses in the hippocampus of rats subjected to EMF radiation during different developmental periods. Male and female rats were first allowed to mate in separate cages. Rats identified as pregnant were then divided into four groups. A 900‐MHz EMF was applied for 2 h daily on gestational days (GD) 1–7, GD 8–14 and GD 15–21. The female offspring were sacrificed at the end of the 28th postnatal day, and PARP‐1 and Caspase‐3 expressions in the hippocampus were then evaluated. No special treatment was applied to the control group. In the EMF‐exposed group, pyramidal neurons in the cornu ammonis (CA) region appeared normal after exposure on GD 1–7 but were darkly stained and shrunken after exposure on GD 15–21, while the majority of granular cells exhibited a normal appearance during all GDs. The group exposed to EMF on GD 15–21 exhibited strong PARP‐1 and Caspase‐3 immune reactivity in CA and dentate gyrus (DG) cells. Higher H‐scores were also observed in the EMF‐exposed group following GD 15–21 irradiation. As a result, a 900‐MHz EMF application at GD 15–21, which coincides with hippocampal neurogenesis, triggered hippocampal neuron cell death by activating PARP‐1 and Caspase‐3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Faculty of Medicine, Kastamonu University, Kastamonu, Turkey.
- Department of Histology and Embryology, Faculty of Veterinary Medicine, Kastamonu University, Kastamonu, Turkey.
- Department of Anatomy, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah, UAE.
- Department of Histology and Embryology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.
ORCID-Profile: Kıymet Kübra Tüfekci, Musa Tatar, Abdalla Ahmed Eldaw Elamin
Zitieren
APA
Tüfekci, K. K., Tatar, M., Elamin, A. A. E., & Kaplan, S. (2025). An Evaluation of Neuronal PARP‐1 and Caspase‐3 Levels in the Brain Tissue of Female Rats Exposed to Electromagnetic Fields at Different Gestational Stages. International Journal of Developmental Neuroscience, 85(1). https://doi.org/10.1002/jdn.70010
Vancouver
Tüfekci KK, Tatar M, Elamin AAE, Kaplan S. An Evaluation of Neuronal PARP‐1 and Caspase‐3 Levels in the Brain Tissue of Female Rats Exposed to Electromagnetic Fields at Different Gestational Stages. International Journal of Developmental Neuroscience. 2025;85(1). doi:10.1002/jdn.70010
BibTeX
@article{Tfekci2025,
author = {Tüfekci, Kıymet Kübra and Tatar, Musa and Elamin, Abdalla Ahmed Eldaw and Kaplan, Süleyman},
title = {An Evaluation of Neuronal PARP‐1 and Caspase‐3 Levels in the Brain Tissue of Female Rats Exposed to Electromagnetic Fields at Different Gestational Stages},
journal = {International Journal of Developmental Neuroscience},
year = {2025},
volume = {85},
number = {1},
doi = {10.1002/jdn.70010}
}
EUVIMED